1Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther, 2000,14:963-978.
2Sachs G, Shin JM, Briving C, et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol,1995,35:277-305.
4Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem,1997,272:22438-22446.
3[2]DOJO M,AZUMA T,SAITO T,et al.Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole),amoxycillin and clarithromycin in Japan[J].Dig Liver Dis,2001,33(8):671 -675.
4[3]SAGAR M,TYBRING G,DAHL M L,et al.Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism[J].Gastroenterology,2000,119(3):670-676.
5[5]FURUTA T,SAGEHASHI Y,SHIRAI N,et al.Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection[J].Clin Gastroenterol Hepatol,2005,3(6):564-573.
6[6]TOGAWA J,INAMORI M,FUJISAWA N,et al.Efficccy of a triple therapy with rabeprazole,amoxicillin,and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy[J].Hepatogastroenterology,2005,52 (62):645-648.
7[7]SAITO M,YASUI-FURUKORI N,UNO T,et al.Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes[J].Br J Clin Pharmacol,2005,59(3):302-309.
8[9]LEE S B,PARK S J,RYU J K,et al.Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype[J].Korean J Gastroenterol,2003,42 (6):468-475.
9[13]SCHWAB M,KLOTZ U,HOFMANN U,et al.Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19:evidence from clinical and pharmacokinetic data[J].Clin Pharmacol Ther,2005,78 (6):627-634.
10[14]SHEU B S,KAO A W,CHENG H C,et al.Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism[J].Aliment Pharmacol Ther,2005,21 (3):283-288.
